Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DZ1 in Nasopharyngeal Carcinoma
NCT01449942Phase 2Completed
- Sponsor
- Xiangya Hospital, Central South University
- Start
- May 2009
- Primary completion
- Apr 2011
- Modality
- Antisense DNA, Small Interfering RNA (siRNA), MicroRNA (miRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of DZ1 in nasopharyngeal carcinoma (NPC), sponsored by Xiangya Hospital, Central South University. Started May 2009; status: completed.
02
Drugs
DZ1
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT01449942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01449942.